Bayer eyes exit from popular Roundup amid US legal risks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 07 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Bayer's Warning to U.S. Lawmakers: Bayer has indicated it may stop selling Roundup weedkiller if better legal protections against product liability lawsuits are not provided, following significant financial settlements related to cancer claims.
Financial Impact and Future of Roundup: The company has set aside $5.9 billion for ongoing litigation and reported that Roundup generated €2.6 billion in revenue last year, but could potentially discontinue the product in the U.S. due to regulatory uncertainties.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
